Amgen (AMGN) Tops Q4 EPS by 56c, Beats on Revenue; Offers FY26 Guidance
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $376.35 --0%
EPS Growth %: +2.7%
Financial Fact:
Provision for income taxes: 401M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +2.7%
Financial Fact:
Provision for income taxes: 401M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $5.29, $0.56 better than the analyst estimate of $4.73. Revenue for the quarter came in at $9.9 billion versus the consensus estimate of $9.46 billion.
GUIDANCE:
Amgen sees FY2026 EPS of $21.60-$23.00, versus the consensus of $22.10. Amgen sees FY2026 revenue of $37-38.4 billion, versus the consensus of $37.1 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Zebra Technologies launches KC401 self-service kiosk for industries
- Nike (NKE) PT Lowered to $42 at UBS on Deteriorating Sales Trends
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
